Question 1

Access to IBD Nurses

Accepted Answer

Chauhan, U., Stitt, L., Rohatinsky, N., Watson, M., Currie, B., Westin, L., ... & Nistor, I. (2022). Patients’ Access to Telephone and E-mail Services Provided by IBD Nurses in Canada. Journal of the Canadian Association of Gastroenterology, 5(3), 129-136. https://doi.org/10.1093/jcag/gwab041 (https://doi.org/10.1093/jcag/gwab041)

Question 2

Understanding of IBD

Accepted Answer

Roda, G., Chien Ng, S., Kotze, P. G., Argollo, M., Panaccione, R., Spinelli, A., ... & Danese, S. (2020). Crohn’s disease. Nature Reviews Disease Primers, 6(1), 1-19. https://doi.org/10.1038/s41572-020-0156-2 (https://doi.org/10.1038/s41572-020-0156-2)(Subscription required)

Mayo Clinic (2019) Ulcerative Colitis.(https://www.mayoclinicproceedings.org/action/showPdf?pii=S0025-6196%2819%2930084-9) (PDF)

Gajendran, M., Loganathan, P., Catinella, A. P., & Hashash, J. G. (2018). A comprehensive review and update on Crohn's disease. Disease-a-month, 64(2), 20-57. https://doi.org/10.1016/j.disamonth.2017.07.001 (https://doi.org/10.1016/j.disamonth.2017.07.001)

Gallo, G., Kotze, P. G., & Spinelli, A. (2018). Surgery in ulcerative colitis: When? How? Best practice & research. Clinical gastroenterology, 32, 71-78. https://doi.org/10.1016/j.bpg.2018.05.017 (https://doi.org/10.1016/j.bpg.2018.05.017)(Subscription required)

Question 3

Disease assessment

Accepted Answer

Gonczi, L., Bessissow, T., & Lakatos, P. L. (2019). Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?. World journal of gastroenterology, 25(41), 6172. doi.org/10.3748/wjg.v25.i41.6172 (doi.org/10.3748/wjg.v25.i41.6172)

Rodrigues, B. L., Mazzaro, M. C., Nagasako, C. K., Ayrizono, M. D. L. S., Fagundes, J. J., & Leal, R. F. (2020). Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores. World Journal of Gastrointestinal Endoscopy, 12(12), 504. doi.org/10.4253/wjge.v12.i12.504 (doi.org/10.4253/wjge.v12.i12.504)

Walsh, A. J., Bryant, R. V., & Travis, S. P. (2016). Current best practice for disease activity assessment in IBD. Nature reviews Gastroenterology & hepatology, 13(10), 567-579. doi.org/10.1038/nrgastro.2016.128 (doi.org/10.1038/nrgastro.2016.128)(Subscription may be required)

Question 4

Medical Management of IBD

Accepted Answer

Review on current and novel treatment for IBD
Abbass, M., Cepek, J., Parker, C. E., Nguyen, T. M., MacDonald, J. K., Feagan, B. G., ... & Jairath, V. (2019). Adalimumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews, (11). doi.org/10.1002/14651858.CD012878.pub2 (doi.org/10.1002/14651858.CD012878.pub2)

Na, S. Y., & Moon, W. (2019). Perspectives on current and novel treatments for inflammatory bowel disease. Gut and Liver, 13(6), 604. doi.org/10.5009/gnl19019 (doi.org/10.5009/gnl19019)

Challenges in maintaining long-term remission
Ashton, J. J., Green, Z., Kolimarala, V., & Beattie, R. M. (2019). Inflammatory bowel disease: Long-term therapeutic challenges. Expert Review of Gastroenterology & Hepatology, 13(11), 1049-1063. doi.org/10.1080/17474124.2019.1685872 ((doi.org/10.1080/17474124.2019.1685872 )Subscription may be required)

Review of strategies to treat to target
Colombel, J. F., D’haens, G., Lee, W. J., Petersson, J., & Panaccione, R. (2020). Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. Journal of Crohn's and Colitis, 14(2), 254-266. doi.org/10.1093/ecco-jcc/jjz131 (doi.org/10.1093/ecco-jcc/jjz131)

Anemia and iron therapy in IBD 
Kumar, A., & Brookes, M. J. (2020). Iron therapy in inflammatory bowel disease. Nutrients, 12(11), 3478. doi.org/10.3390/nu12113478 (doi.org/10.3390/nu12113478)

Patel, D., Trivedi, C., & Khan, N. (2018). Management of anemia in patients with inflammatory bowel disease (IBD). Current treatment options in gastroenterology, 16(1), 112-128. doi.org/10.1007/s11938-018-0174-2 (doi.org/10.1007/s11938-018-0174-2)(Subscription may be required)

Strategies to manage perianal disease
Nguyen, G. C. (2018). The Bottom Line: A Multidisciplinary Approach Is Key to Treating Perianal Fistulizing Crohn’s Disease. Journal of the Canadian Association of Gastroenterology, 1(4), 139. doi.org/10.1093/ecco-jcc/jjz131 (doi.org/10.1093/ecco-jcc/jjz131)

Treat to target strategies and review on STRIDE-II
Turner, D., Ricciuto, A., Lewis, A., D’amico, F., Dhaliwal, J., Griffiths, A. M., ... & Dignass, A. (2021). STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology, 160(5), 1570-1583. doi.org/10.1053/j.gastro.2020.12.031 (doi.org/10.1053/j.gastro.2020.12.031)

Practical guide for thiopurine monitoring in IBD.  
Warner, B., Johnston, E., Arenas-Hernandez, M., Marinaki, A., Irving, P., & Sanderson, J. (2018). A practical guide to thiopurine prescribing and monitoring in IBD. Frontline Gastroenterology, 9(1), 10-15. doi.org/10.1136/flgastro-2016-100738 (doi.org/10.1136/flgastro-2016-100738)

Question 5

Management of IBD in Special Populations

Accepted Answer

Singh, S., Picardo, S., & Seow, C. H. (2020). Management of inflammatory bowel diseases in special populations: obese, old, or obstetric. Clinical Gastroenterology and Hepatology, 18(6), 1367-1380. https://doi.org/10.1016/j.cgh.2019.11.009 (https://doi.org/10.1016/j.cgh.2019.11.009)(Subscription may be required)

Question 6

Preventative care in IBD

Accepted Answer

Leddin, D., Lieberman, D. A., Tse, F., Barkun, A. N., Abou-Setta, A. M., Marshall, J. K., ... & Leontiadis, G. I. (2018). Clinical practice guideline on screening for colorectal cancer in individuals with a family history of nonhereditary colorectal cancer or adenoma: the Canadian Association of Gastroenterology Banff Consensus. Gastroenterology, 155(5), 1325-1347. doi.org/10.1053/j.gastro.2018.08.017 (doi.org/10.1053/j.gastro.2018.08.017)

Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017). ACG clinical guideline: preventive care in inflammatory bowel disease. Official journal of the American College of Gastroenterology| ACG, 112(2), 241-258. doi.org/10.1038/ajg.2016.537 (doi.org/10.1038/ajg.2016.537)

Abegunde, A. T., Muhammad, B. H., & Ali, T. (2016). Preventive health measures in inflammatory bowel disease. World journal of gastroenterology, 22(34), 7625. doi.org/10.3748/wjg.v22.i34.7625  (doi.org/10.3748/wjg.v22.i34.7625)

Question 7

Understanding and managing bile acid malabsorption in IBD

Accepted Answer

Sadowski, D. C., Camilleri, M., Chey, W. D., Leontiadis, G. I., Marshall, J. K., Shaffer, E. A., ... & Walters, J. R. (2020). Canadian Association of Gastroenterology clinical practice guideline on the management of bile acid diarrhea. Journal of the Canadian Association of Gastroenterology, 3(1), e10-e27. doi.org/10.1093/jcag/gwz038 (doi.org/10.1093/jcag/gwz038)

Vítek, L. (2015). Bile acid malabsorption in inflammatory bowel disease. Inflammatory bowel
diseases, 21(2), 476-483. doi.org/10.1097/MIB.0000000000000193 (doi.org/10.1097/MIB.0000000000000193)

Question 8

Review of adverse effects from biologics

Accepted Answer

Click, B. & Regueiro, M. Managing risks with biologics. Current Gastroenterology Reports 21.1 (2019): 1-11. doi.org/10.1007/s11894-019-0669-6 ( doi.org/10.1007/s11894-019-0669-6)(Subscription may be required)

Quezada, S. M., McLean, L. P., & Cross, R. K. (2018). Adverse events in IBD therapy: the 2018 update. Expert Review of Gastroenterology & Hepatology, 12(12), 1183-1191. doi.org/10.1080/17474124.2018.1545574 (doi.org/10.1080/17474124.2018.1545574)(Subscription may be required)

Question 9

Abdominal Discomfort

Accepted Answer

Nistor, O. I., Godfrey, C., Ross-White, A., & Wilson, R. (2022). Systematic Review and Meta-analysis on the Incidence, Prevalence and Determinants of Discomfort in Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology, 5(2), 96-97. doi.org/10.1093/jcag/gwab043 (doi.org/10.1093/jcag/gwab043)

Question 10

Extraintestinal manifestations of IBD

Accepted Answer

Bernstein, C. N., Benchimol, E. I., Bitton, A., Murthy, S. K., Nguyen, G. C., Lee, K., ... & Kaplan, G. G. (2019). The impact of inflammatory bowel disease in Canada 2018: Extra-intestinal diseases in IBD. Journal of the Canadian Association of Gastroenterology, 2(Supplement_1), S73-S80. doi.org/10.1093/jcag/gwy053 (doi.org/10.1093/jcag/gwy053)

Garber, A., & Regueiro, M. (2019). Extraintestinal manifestations of inflammatory bowel disease: epidemiology, etiopathogenesis, and management. Current gastroenterology reports, 21(7), 1-13. doi.org/10.1007/s11894-019-0698-1 (doi.org/10.1007/s11894-019-0698-1)

Yokoda, R. T., & Carey, E. J. (2019). Primary biliary cholangitis and primary sclerosing cholangitis. Official journal of the American College of Gastroenterology| ACG, 114(10), 1593-1605. doi.org/10.14309/ajg.0000000000000268 (doi.org/10.14309/ajg.0000000000000268)(Subpscription may be required)

Question 11

Mental health & IBD

Accepted Answer

Dubinsky, M. C., Dotan, I., Rubin, D. T., Bernauer, M., Patel, D., Cheung, R., ... & Keefer, L. (2021). Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review. Expert review of gastroenterology & hepatology, 15(9), 985-997. doi.org/10.1080/17474124.2021.1911644 (doi.org/10.1080/17474124.2021.1911644)

Graff, L. A., Fowler, S., Jones, J. L., Benchimol, E. I., Bitton, A., Huang, J. G., ... & Bernstein, C. N. (2021). Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life. Journal of the Canadian Association of Gastroenterology, 4(Supplement_2), S46-S53. doi.org/10.1093/jcag/gwab031 (doi.org/10.1093/jcag/gwab031)

Qazi, T. (2020). Fatigue in inflammatory bowel disease: A problematic ailment. Current Opinion in Gastroenterology, 36(4), 284-294. doi.org/10.1097/mog.0000000000000644 ((doi.org/10.1097/mog.0000000000000644 )Subscription may be required)

Question 12

Diet & IBD

Accepted Answer

Ghishan, F. K., & Kiela, P. R. (2017). Vitamins and minerals in inflammatory bowel disease. Gastroenterology Clinics, 46(4), 797-808. doi.org/10.1007/s11938-019-00248-z (doi.org/10.1007/s11938-019-00248-z)(Subscription may be required)

Green, N., Miller, T., Suskind, D., & Lee, D. (2019). A review of dietary therapy for IBD and a vision for the future. Nutrients, 11(5), 947. doi.org/10.3390/nu11050947 (doi.org/10.3390/nu11050947)

Gu, P., & Feagins, L. A. (2020). Dining with inflammatory bowel disease: a review of the literature on diet in the pathogenesis and management of IBD. Inflammatory Bowel Diseases, 26(2), 181-191. doi.org/10.1093/ibd/izz268 (doi.org/10.1093/ibd/izz268)

Li, S., Ney, M., Eslamparast, T., Vandermeer, B., Ismond, K. P., Kroeker, K., ... & Tandon, P. (2019). Systematic review of nutrition screening and assessment in inflammatory bowel disease. World journal of gastroenterology, 25(28), 3823. doi.org/10.3748/wjg.v25.i28.3823 (doi.org/10.3748/wjg.v25.i28.3823)

Mentella, M. C., Scaldaferri, F., Pizzoferrato, M., Gasbarrini, A., & Miggiano, G. A. D. (2020). Nutrition, IBD and gut microbiota: a review. Nutrients, 12(4), 944. doi.org/10.3390/nu12040944 (doi.org/10.3390/nu12040944)

Picardo, S., Altuwaijri, M., Devlin, S. M., & Seow, C. H. (2020). Complementary and alternative medications in the management of inflammatory bowel disease. Therapeutic Advances in Gastroenterology, 13, 1756284820927550. doi.org/10.1177/1756284820927550 (doi.org/10.1177/1756284820927550)

Weber, A. T., Shah, N. D., Sauk, J., & Limketkai, B. N. (2019). Popular diet trends for inflammatory bowel diseases: claims and evidence. Current Treatment Options in Gastroenterology, 17(4), 564-576. doi.org/10.1007/s11938-019-00248-z (doi.org/10.1007/s11938-019-00248-z)(Subscription may be required)

Question 13

Sexual health and fertility with IBD

Accepted Answer

Ananthakrishnan, A. N., Martin, C., Kane, S., Sandler, R. S., & Long, M. D. (2019). Paternal disease activity is associated with difficulty in conception among men with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology, 17(1), 203-204. doi.org/10.1016/j.cgh.2018.04.001  (doi.org/10.1016/j.cgh.2018.04.001 )

Leenhardt, R., Rivière, P., Papazian, P., Nion-Larmurier, I., Girard, G., Laharie, D., & Marteau, P. (2019). Sexual health and fertility for individuals with inflammatory bowel disease. World Journal of Gastroenterology, 25(36), 5423. doi.org/10.3748/wjg.v25.i36.5423 (doi.org/10.3748/wjg.v25.i36.5423)
​
Management of IBD during pregnancy
Nguyen, G. C., Seow, C. H., Maxwell, C., Huang, V., Leung, Y., Jones, J., ... & Paterson, W. (2016). The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology, 150(3), 734-757. doi.org/10.1053/j.gastro.2015.12.003 (doi.org/10.1053/j.gastro.2015.12.003)

PUBLICATIONS